Accueil / Tag Archives: New-York (page 6)

Tag Archives: New-York

Center for Biotechnology to Showcase Next-Gen Industry Leaders

Thursday, October 24th 2019 at 6:00pm UTC Annual Life Sciences Summit connects emerging companies with the capital and partners necessary to move breakthroughs into and through clinical development NEW YORK–(BUSINESS WIRE)– The Center for Biotechnology (CfB) will welcome hundreds of companies, investors and strategic partners from across the country to …

Plus »

Eleusis Presents New Research on the Anti-Inflammatory Potential of Serotonin 2A Receptor Agonists at the 2019 International Society for Research on Psychedelics

Wednesday, October 23rd 2019 at 1:00pm UTC — New Research Reveals Broad-Based Anti-Inflammatory Potential of Serotonin 2A Receptor Agonists at Inaugural Scientific Meeting LONDON & NEW YORK–(BUSINESS WIRE)– Eleusis, a clinical stage life science company established to develop the therapeutic potential of serotonin 2A receptor (5-HT2A) agonists, also known as …

Plus »

Columbia Care Announces Voluntary Lock-Up Extension Amendments with Company Founders, Board Members and Leadership Team

Wednesday, October 23rd 2019 at 12:59pm UTC NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced that the Company founders, …

Plus »

Propanc Biopharma Illustrates Novel Mode of Action of PRP, Suppressing EMT Pathways and Metastasis in Cancer Patients

Monday, October 21st 2019 at 12:30pm UTC PRP a Potential Method for Reducing Recurrence After Drug Treatment Failures Global Metastatic Cancer Treatment Market Anticipated to Reach $98.24 Billion By 2025 MELBOURNE, Australia–(BUSINESS WIRE)– Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new cancer treatments for …

Plus »

Rocket Pharmaceuticals Announces Clearance of IND for RP-L301 Gene Therapy for Pyruvate Kinase Deficiency

Tuesday, October 22nd 2019 at 11:00am UTC –Rocket’s Largest Lentiviral Pipeline Opportunity with an Estimated Prevalence of 3,000 to 8,000 Patients in the U.S. and EU– –Precedent-Setting Global Phase 1 Study with Commercial Manufacturer is Now Enrolling– NEW YORK–(BUSINESS WIRE)– Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform …

Plus »

Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes

Friday, October 18th 2019 at 10:59am UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration date of the offers to exchange (the “Exchange Offers”) notes (the “Celgene Notes”) issued by Celgene Corporation (NASDAQ:CELG) (“Celgene”) for up to $19,850,000,000 aggregate principal amount of …

Plus »

Arrowhead Pharmaceuticals Hosts R&D Day on Emerging Pipeline of RNAi Therapeutics

Friday, October 18th 2019 at 11:30am UTC PASADENA, Calif.–(BUSINESS WIRE)– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is hosting a Research & Development (R&D) Day today in New York to discuss its emerging pipeline of RNAi therapeutics that leverage its proprietary Targeted RNAi Molecule Platform (TRiM™) platform. The event will feature presentations …

Plus »

Compulink Showcases AI-Powered, All-in-One Orthopaedic EHR Solution at ASES 2019

Wednesday, October 16th 2019 at 5:58pm UTC NEWBURY PARK, Calif.–(BUSINESS WIRE)– Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will showcase its Orthopaedic Advantage™ suite of Ortho-specific solutions at the American Shoulder and Elbow Surgeons annual meeting …

Plus »

Can-Fite BioPharma Interview to Air on Bloomberg International on the RedChip Money Report

Wednesday, October 16th 2019 at 11:00am UTC PETACH TIKVA, Israel–(BUSINESS WIRE)– Can-Fite BioPharma Ltd. (NYSE American: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced an interview with CEO Pnina Fishman Ph.D. will air on The RedChip Money …

Plus »

Oligomerix, Inc. to Present Data on Lead Alzheimer’s Disease Candidate at Neuroscience 2019

Wednesday, October 16th 2019 at 1:00pm UTC — Compound is an oral small molecule inhibitor of tau aggregation — NEW YORK–(BUSINESS WIRE)– Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer’s disease (AD) and related neurodegenerative disorders, will present preclinical data on its lead …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.